设为首页 加入收藏

TOP

MYLOTARG Injection 5mg(マイロターグ点滴静注用5mg)
2015-11-16 06:42:51 来源: 作者: 【 】 浏览:602次 评论:0

Pfizer Pharmaceuticals Inc.

Injection
Revised: 9/2012

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
MYLOTARG Injection 5mg
 Active ingredient:
Gemtuzumab Ozogamicin (Genetical Recombination)
 Dosage form:
injection
 Print on wrapping:
 

Effects of this medicine

This medicine, a combination with humanized anti-CD33 antibodies and derivative of anti-tumor antibiotics, has an anti-tumor effect through cytocidal activation by ingesting into the leukemia cell that expresses CD33 antigen.
Usually, used for treatment of recurrent or refractory CD33-positive acute myelocytic leukemia.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have: liver disorder, renal disorder, infection, lung disorder.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is <<        to be written by a healthcare professional>>
  • In general, for adults, this medicine is administered intravenously for 2 hours at a time. This preparation is injected twice with dosing interval of at least 14 days.
    The treatment period with this medicine is determined according to the symptoms.

Precautions while taking this medicine

  • Avoid pregnancy, if you are at risk of becoming pregnant.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include fever, nausea, dullness, loss of appetite, vomiting, chill, headache, nose bleeding, weight loss, infection, tachycardia, sepsis (chill, fever, breathing difficulty), feeling of weakness, diarrhea and abdominal pain. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • chill, fever, nausea [infusion reaction]
  • dullness, fever, bleeding tendency [hematological disorder (myelosuppression, etc.)]
  • sudden high fever with trembling, palpitation, discomfort in the chest [infection]
  • headache, abdominal pain, vomiting blood [bleeding]
  • dullness, loss of appetite, yellowing of the skin or whites of the eyes [liver disorder]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

  •  
以下是“全球医药”详细资料
Tags: 责任编辑:admin
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇MINIRINMELT OD Tablet 120mcg [f.. 下一篇MINIRINMELT OD Tablet(Desmopre..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位